HYFT

ImmunoPrecise Antibodies Ltd.
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$65.01M
P/E Ratio
—
EPS
$-0.26
Beta
0.83
52W High
$2.99
52W Low
$0.99
50-Day MA
$1.35
200-Day MA
$1.48
Dividend Yield
—
Profit Margin
-105.20%
Forward P/E
—
PEG Ratio
—

About ImmunoPrecise Antibodies Ltd.

MindWalk Holdings Corp. The company is headquartered in Austin, Texas.

Official WebsiteUSAFY End: April

Fundamentals

Revenue (TTM)$16.23M
Gross Profit (TTM)$9.87M
EBITDA$-16.10M
Operating Margin-159.90%
Return on Equity-123.70%
Return on Assets-36.40%
Revenue/Share (TTM)$0.35
Book Value$0.11
Price-to-Book13.98
Price-to-Sales (TTM)4.01
EV/Revenue5.71
EV/EBITDA-4.68
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)21.30%
Shares Outstanding$47.11M
Float$42.68M
% Insiders9.14%
% Institutions9.29%

Historical Volatility

HV 10-Day
123.42%
HV 20-Day
90.24%
HV 30-Day
82.30%
HV 60-Day
88.22%
HV Rank
22.2%

Volatility is currently expanding

Analyst Ratings

Consensus ($4.33 target)
3
Buy

Latest News

MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced results from a production deployment of the open-source OpenFold3 structure prediction model, run with engineering partners AMD and Vultr on Vultr Kubernetes Engine and Vultr Cloud GPU powered by AMD Instinct™ MI325X GPUs and delivered through AMD Inference Microservices (AIM). It also served as an independent validation of AIM for OpenFold3 in a production life-sciences.

Business Wire9/21/2026Neutral
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has entered into a binding commitment with Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million. The facility is intended to support MindWalk's biologics programs, commercial expansion, working capital, and general corporate purposes. The facility carries a fixed annual interest rate of 7.00%, accruing only on amounts drawn, an.

Business Wire9/14/2026Neutral
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD's Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct™ Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMD's channels. The demonstration is the first.

Business Wire7/23/2026Neutral
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has been added to the Russell 3000E Index, effective after the U.S. market close on June 26, 2026, as part of the FTSE Russell June 2026 semi-annual Russell US Indexes Reconstitution. Membership was reconfirmed in index data published June 29, 2026. The Russell 3000E Index is FTSE Russell's broadest measure of the U.S. equity market, covering up to the 4,000 of t.

Business Wire7/6/2026Neutral
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced the filing of European patent application No. EP26187897.9, directed to high-dimensional data structures for biological subsequences and property inference. The application is intended to protect the enriched biological representation architecture that underpins MindWalk's HYFT® Technology, its ReefIQ™ biological context layer, and its LensAI™ reasoning workflows. The fi.

Business Wire7/1/2026Neutral
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery

VICTORIA, British Columbia--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a bio-native AI company, today launched ReefIQ™, a HYFT-powered biological context layer for AI drug discovery and biologics development, that sits between client discovery data and AI reasoning workflows. Biology is connected, but drug-discovery data is often fragmented across files, formats, systems, teams, and workflows. ReefIQ reconnects those representations before AI workflows act on them, li.

Business Wire6/10/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HYFT and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/28/2026